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Great Expectations—SID and Industry 
Relationship: A 20-Year Perspective
How is the SID perceived by industry?” was the dart that Luis Diaz let fly at my first SID Board meeting. Should I quip, 
“If the doors of perception were cleansed every-
thing would appear to man as it is, infinite” (Blake, 
1957), or “What is truth?” (Austin, 1961), or, per-
haps more appropriately, should I quote the phrase 
from John Milton’s On His Blindness: “They also 
serve who only stand and wait”? Instead, I left 
the English classics behind and elaborated my 
response with more hand waving than words (my 
European genes), submitting to the Board that the 
situation presented more of an opportunity than 
a concern. Well, at least I got invited back to the 
next Board meeting.
I deviate momentarily to give you a little back-
ground information. I joined the SID in 1982 and 
have enjoyed dual membership with the ESDR 
since that time. The first meeting I attended in 
Washington, DC (we could all fit in the Capital 
Hilton at that time), was marred by an intruder 
who, on the first evening, waltzed through the 
hotel rooms of unsuspecting Europeans (we don’t 
lock doors), relieving them of valuables, money, 
and identity. But things only got better. In May 
2000, I was elected to serve on the SID Board of 
Directors. Few scientists from private industry had 
enjoyed this honor. It was my perception that “the 
Society” viewed “Industry” as the “dark side,” 
where science was as rare and reactive as a noble 
gas. From the outset, a blend of a businesslike atti-
tude and warm cordiality put me at ease as I sat 
through my first meeting, although it was not long 
before a debate kindled.
Managing the interface between a learned soci-
ety and the pharmaceutical industry requires rela-
tive clarity on the viewpoints of each stakeholder. It 
was with this principle that I accepted a challenge 
from the then Secretary–Treasurer of the SID, now 
our esteemed Editor-in-Chief, Paul Bergstresser. A 
man of few words, he said, “Enhance the relation-
ship!” I boldly agreed, thinking that this would be 
a simple matter of dialogue and reassurance.
I had attended platforms that the Society creat-
ed in 1997 under the presidency of John Vorhees. 
These took the form of a luncheon, where phar-
maceutical leaders were invited to give talks 
about their companies, their interests, and their 
personal views. I had the opportunity to give one 
of these talks and, despite polite acclaim, I felt 
the value accrued was minimal (a thought sadly 
shared by co-speakers Geert Cauwenbergh and 
Stanley Shapiro—“falling on deaf ears” was the 
only publishable comment). But during dessert 
and coffee, Anton Stutz said “the problem is 'they' 
don’t realize the complexity of what we do, nor 
do 'they' understand why we do it.” That was the 
“aha” moment I was searching for. I went back 
to the Board and presented the perception issues 
and proposed a joint task force consisting of SID 
leadership and R&D personnel from a number of 
companies, including Allergan, Amgen, Astellis, 
Galderma, Johnson & Johnson, and Novartis. The 
recommendation that resulted from several meet-
ings was, in summary, that we replace the lun-
cheon talks with an annual workshop, themed to 
reflect aspects of investigative dermatology that 
were important to the industry. The workshops 
would provide a platform for speakers from both 
academic and industry sources, incorporating 
facets of the theme singular to industry. For exam-
ple, regulatory matters, clinical trial design out-
come measurements, and pharmacoeconomics 
could be part of the workshop when appropriate. 
Besides the workshop at the annual meeting, we 
convened a round-up session at which all industry 
attendees were invited to express their comments 
about the meeting to the Society leadership. In 
addition, comments on the workshop were wel-
comed and requests for future themes sought. Five 
such workshops took place:
2000: The Changing Face of Commercial 
Dermatology Research
2001: Photoprotection: Concepts and Practice
2002: Economic Outcomes in Dermatologic 
Clinical Trial Design
2003: Cell-Based Therapeutics in Dermatology
2004: Understanding Translational Research
In 2005, we saw the smooth transition to 
Translational Research Workshops pioneered by 
Seth Stevens. These represented a further focus on 
progressing concepts from the bench to the bed-
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side, a topic of relevance to all biomedical research. Although 
there is no magic wand to effect sudden change, these sessions, 
over time, resulted in a better awareness of industry science at 
the SID leadership level and prompted the renewed presence 
on the Board of an Industry Senior Scientist (Anton Stutz).
The fact that industry seeks to protect its ideas through pat-
ents and other forms of intellectual property is often cited as a 
reason that hot topics are not presented by industry. Insistence 
on patents may delay publication, but it permits fuller exposure 
of the science behind products when they reach the market. It 
should be noted that more and more universities protect their 
research with patents, thus enabling a more frank and tangi-
ble discussion with third parties interested in developing their 
novel technologies.
Strategic planning is a cornerstone in the universe of indus-
try, so I was most interested to participate in the Strategic 
Planning Retreat led by David Bickers in 2003. The product of 
this meeting, “Vision 2008,” resulted in a focus on key objec-
tives for the SID, one of which was attracting industry support 
for concurrent symposia, which now enjoy high attendance at 
the annual meeting. The SID and sponsors work closely togeth-
er to ensure that stringent guidelines are implemented, resulting 
in unbiased investigative research presentations on themes of 
interest. Essentially, this evolution from the workshop concept 
to concurrent symposia has been an effective vehicle to con-
vey the dialogue we sought to create. We should anticipate that 
researchers from any company could share valuable research 
information with their peers at such a venue.
A further outcome of the Strategic Planning Retreat was the 
crystallization of the concept that education was a key mission 
of the Society. I began to reflect on how this could be imple-
mented within my brief of Industry Liaison. Discussion with 
Kevin Cooper and Jean Bolognia, catalyzed by Paul Bergstresser, 
led to the creation of a course to be taught on an annual basis, 
”SID Basics of Skin: Pharmaceutics & Pharmacology.” The pro-
gram primarily addresses scientists and clinicians working in the 
industry who, despite experience in basic disciplines, may be 
unfamiliar with the applicability of that knowledge in the con-
text of skin. The course is taught over an intensive two and a 
half days by the best faculty the SID can offer. This is an added 
attraction to potential attendees because they not only receive 
the opportunity to learn at the feet of the experts but also have 
occasion to interact with and question the experts directly in 
breakout sessions. These courses have been held since 2004, in 
Philadelphia, San Antonio, and San Diego. Expressly, there are 
few attendees (a maximum of 60). The course has blossomed 
and individuals have returned to hear again the core elements of 
structure, function, and formulation science, together with new 
specialized topics on skin disease. Companies use this course 
to give their discovery scientists grounding in our specialty. 
Interestingly, individuals with roles in areas other than research, 
including regulatory, clinical, and scientific liaison specialists, 
have attended the course. This course has also attracted the 
interest of dermatology residents, who have gained a grasp of the 
basics. An impressive course book distributed at the outset of the 
meeting is produced thanks to the hard work of the SID office 
staff. Finally, the course introduces industry researchers to one 
another and allows exchange of non-confidential information, 
leading to bonds of friendship and respect. Last to be noted is 
the jewel in the crown of the Society. The Journal of Investigative 
Dermatology, by insisting on a high academic standard, is the 
primary resource for publications of companies engaged in 
skin-related research and development. This provides one more 
reason that industry is drawn favorably to the Society.
As an interesting digestif, I offer Table 1, showing SID mem-
bership affiliations in academia versus industry. The latter saw a 
marked increase in 1997, which has been sustained.
My overall observation is that the dialogue created between 
SID leadership and pharmaceutical industry representatives 
has continued as the Society presidents have rotated. Wright 
Caughman and Bob Swerlick, in the role of Secretary–Treasurer, 
both supported the programs in word and deed. (Bob Swerlick 
delivers a highly acclaimed immunology course at the Basics of 
Skin meeting.)
Only time and example will wash away the preconceived 
notions held by both the professional society and the industry 
that were cited at the beginning of this commentary. As a result 
of the initiatives taken by the SID in the past six years, the con-
troversy will diminish in intensity like the ebb tide. Deploying 
similar initiatives with our sister organizations, the ESDR and 
JSID, would bring more light to the matter.
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Table 1. SID member statistics: affi liation and 
academia, 1991 to present
Year Academia Industry
1991 405 46
1992 404 50
1993 424 53
1994 510 57
1995 519 66
1996 562 80
1997 604 173
1998 574 249
1999 1014 237
2000 985 217
2001 1023 239
2002 1022 241
2003 1006 228
2004 1021 258
2005 978 255
2006 1012 246
2007 939 235
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